Regulatory Flexibilities Balancing Unmet Needs, Benefits and Risks in the Approvals of Imported Cancer Drugs in China: a Cohort Study From 2012 to 2021

Program On Regulation, Therapeutics, And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital • Harvard Medical School
41 Avenue Louis Pasteur, Suite 0B17, Boston, MA 02115